SFI
ALXN

Siemens Fonds Invest’s Alexion Pharmaceuticals ALXN Stock Holding History

Siemens Fonds Invest’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,044
Closed -$1.88M – 200
2020
Q4 		$1.88M Buy
+12,044
New +$1.55M 0.19% 129

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Siemens Fonds Invest's ALXN Position: Q1 2021 in Review

Siemens Fonds Invest sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 12,044 shares — an estimated $1.88M sold.

Siemens Fonds Invest first reported a position in ALXN in Q4 2020 and held it in 1 quarter. The position peaked at $1.88M in Q4 2020. 753 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Siemens Fonds Invest reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Siemens Fonds Invest sold 12,044 Alexion Pharmaceuticals shares in Q1 2021, an estimated $1.88M.
  • Siemens Fonds Invest first reported a position in Alexion Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • Siemens Fonds Invest's Alexion Pharmaceuticals position peaked at $1.88M in Q4 2020.
  • 753 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Siemens Fonds Invest's 13F filing for Q1 2021, filed 14 Jul 2021.